Developmental origin, functional maintenance and genetic rescue of osteoclasts.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2019
Historique:
received: 10 04 2018
accepted: 06 03 2019
pubmed: 12 4 2019
medline: 18 12 2019
entrez: 12 4 2019
Statut: ppublish

Résumé

Osteoclasts are multinucleated giant cells that resorb bone, ensuring development and continuous remodelling of the skeleton and the bone marrow haematopoietic niche. Defective osteoclast activity leads to osteopetrosis and bone marrow failure

Identifiants

pubmed: 30971820
doi: 10.1038/s41586-019-1105-7
pii: 10.1038/s41586-019-1105-7
pmc: PMC6910203
mid: NIHMS1052671
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-545

Subventions

Organisme : NCI NIH HHS
ID : T32 CA009149
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI130345
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL138090
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG032959
Pays : United States

Références

Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176 (1998).
Kong, Y. Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315–323 (1999).
pubmed: 9950424
Dougall, W. C. et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412–2424 (1999).
pubmed: 10500098 pmcid: 317030
Hsu, H. et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl Acad. Sci. USA 96, 3540–3545 (1999).
pubmed: 10097072
Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442–444 (1990).
pubmed: 2188141
Dai, X.-M. et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111–120 (2002).
pubmed: 11756160
Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015–1024 (1999).
pubmed: 10215628 pmcid: 316636
Tondravi, M. M. et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81–84 (1997).
pubmed: 9052784
Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889–901 (2002).
pubmed: 12479813
Lau, R. Y. & Guo, X. A review on current osteoporosis research: with special focus on disuse bone loss. J. Osteoporos. 2011, 293808 (2011).
pubmed: 21876833 pmcid: 3160709
Coccia, P. F. et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N. Engl. J. Med. 302, 701–708 (1980).
pubmed: 6986555
Sorell, M. et al. Marrow transplantation for juvenile osteopetrosis. Am. J. Med. 70, 1280–1287 (1981).
pubmed: 7015858
Walker, D. G. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 190, 784–785 (1975).
pubmed: 1105786
Ballet, J. J., Griscelli, C., Coutris, C., Milhaud, G. & Maroteaux, P. Bone-marrow transplantation in osteopetrosis. Lancet 2, 1137 (1977).
pubmed: 73050
Nisbet, N. W., Menage, J. & Loutit, J. F. Bone-marrow transplantation in osteopetrosis. Lancet 2, 1236 (1977).
pubmed: 73939
Ash, P., Loutit, J. F. & Townsend, K. M. Osteoclasts derived from haematopoietic stem cells. Nature 283, 669–670 (1980).
pubmed: 7354855
Orchard, P. J. et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood 126, 270–276 (2015).
pubmed: 26012570 pmcid: 4497967
Frattini, A. et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc. Natl Acad. Sci. USA 102, 14629–14634 (2005).
pubmed: 16195375
Jotereau, F. V. & Le Douarin, N. M. The development relationship between osteocytes and osteoclasts: a study using the quail-chick nuclear marker in endochondral ossification. Dev. Biol. 63, 253–265 (1978).
pubmed: 346418
Shalhoub, V. et al. Characterization of osteoclast precursors in human blood. Br. J. Haematol. 111, 501–512 (2000).
pubmed: 11122091
McGrath, K. E. et al. Distinct sources of hematopoietic progenitors emerge before HSCs and provide functional blood cells in the mammalian embryo. Cell Reports 11, 1892–1904 (2015).
pubmed: 26095363 pmcid: 4490098
Gomez Perdiguero, E. et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547–551 (2015).
pubmed: 25470051
Maroteaux, P. & Lamy, M. Pyknodysostosis. Presse Med. 70, 999–1002 (1962).
pubmed: 14470123
Gelb, B. D., Shi, G. P., Chapman, H. A. & Desnick, R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236–1238 (1996).
pubmed: 8703060
Taniguchi, N. et al. Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol. Cell. Biol. 27, 5650–5663 (2007).
pubmed: 17548469 pmcid: 1952123
Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012).
pubmed: 22442384
Mass, E. et al. Specification of tissue-resident macrophages during organogenesis. Science 353, aaf4238 (2016).
pubmed: 27492475 pmcid: 5066309
Percin, G. I. et al. CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages. Nat. Commun. 9, 5279 (2018).
pubmed: 30538245 pmcid: 6290072
Walker, D. G. Osteopetrosis cured by temporary parabiosis. Science 180, 875 (1973).
pubmed: 4706681
Deng, L. et al. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am. J. Pathol. 176, 952–967 (2010).
pubmed: 20042677 pmcid: 2808099
Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222–225 (2011).
pubmed: 21654748 pmcid: 3208506
Li, J., Chen, K., Zhu, L. & Pollard, J. W. Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. Genesis 44, 328–335 (2006).
pubmed: 16823860
Benz, C., Martins, V. C., Radtke, F. & Bleul, C. C. The stream of precursors that colonizes the thymus proceeds selectively through the early T lineage precursor stage of T cell development. J. Exp. Med. 205, 1187–1199 (2008).
pubmed: 18458114 pmcid: 2373849
Mucenski, M. L. et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677–689 (1991).
pubmed: 1709592
Stadtfeld, M. & Graf, T. Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development 132, 203–213 (2005).
pubmed: 15576407
Hanada, R. et al. Central control of fever and female body temperature by RANKL/RANK. Nature 462, 505–509 (2009).
pubmed: 19940926
Maeda, K. et al. Wnt5a–Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18, 405–412 (2012).
pubmed: 22344299
Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell 130, 811–823 (2007).
pubmed: 17803905
Hameyer, D. et al. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol. Genomics 31, 32–41 (2007).
pubmed: 17456738
Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
pubmed: 11299042 pmcid: 31338
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
pubmed: 20023653
Kamran, P. et al. Parabiosis in mice: a detailed protocol. J. Vis. Exp. 80, e50556 (2013).
Jiang, X. et al. Histological analysis of GFP expression in murine bone. J. Histochem. Cytochem. 53, 593–602 (2005).
pubmed: 15872052
Filgueira, L. Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J. Histochem. Cytochem. 52, 411–414 (2004).
pubmed: 14966208
Arndt, K. et al. SETD1A protects HSCs from activation-induced functional decline in vivo. Blood 131, 1311–1324 (2018).
pubmed: 29348130
Grinenko, T. et al. Clonal expansion capacity defines two consecutive developmental stages of long-term hematopoietic stem cells. J. Exp. Med. 211, 209–215 (2014).
pubmed: 24446490 pmcid: 3920556

Auteurs

Christian E Jacome-Galarza (CE)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Gulce I Percin (GI)

Regeneration in Hematopoiesis and Animal Models in Hematopoiesis, Institute for Immunology, Dresden, Germany.
Regeneration in Hematopoiesis, Leibniz Institute on Aging-Fritz Lipmann Institute (FLI), Faculty of Biological Sciences, Friedrich-Schiller University, Jena, Germany.

James T Muller (JT)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Elvira Mass (E)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Developmental Biology of the Innate Immune System, LIMES Institute, University of Bonn, Bonn, Germany.

Tomi Lazarov (T)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jiri Eitler (J)

Regeneration in Hematopoiesis and Animal Models in Hematopoiesis, Institute for Immunology, Dresden, Germany.

Martina Rauner (M)

Department of Medicine III, Faculty of Medicine, Dresden, Germany.

Vijay K Yadav (VK)

Department of Genetics and Development, Columbia University Medical Center, New York, NY, USA.

Lucile Crozet (L)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Mathieu Bohm (M)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Pierre-Louis Loyher (PL)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Gerard Karsenty (G)

Department of Genetics and Development, Columbia University Medical Center, New York, NY, USA.

Claudia Waskow (C)

Regeneration in Hematopoiesis and Animal Models in Hematopoiesis, Institute for Immunology, Dresden, Germany. claudia.waskow@leibniz-fli.de.
Regeneration in Hematopoiesis, Leibniz Institute on Aging-Fritz Lipmann Institute (FLI), Faculty of Biological Sciences, Friedrich-Schiller University, Jena, Germany. claudia.waskow@leibniz-fli.de.
Department of Medicine III, Faculty of Medicine, Dresden, Germany. claudia.waskow@leibniz-fli.de.

Frederic Geissmann (F)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. geissmaf@mskcc.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH